Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Saved in:
| Title: | Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial. |
|---|---|
| Authors: | Rousel J; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands., Saghari M; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands., Pagan L; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands., Nădăban A; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands., Gambrah T; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., Theelen B; Westerdijk Fungal Biodiversity Institute, 3508 AD Utrecht, The Netherlands., de Kam ML; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., Haakman J; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., van der Wall HEC; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., Feiss GL; Cutanea Life Sciences, Wayne, PA 19087, USA., Niemeyer-van der Kolk T; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., Burggraaf J; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands., Bouwstra JA; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands., Rissmann R; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands., van Doorn MBA; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Department of Dermatology, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2023 Sep 20; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 20. |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms241814315 |
